Abstract
Triiodothyronine (T3) has been shown to accelerate and potentiate the clinical response to tricyclic antidepressant (TCA) treatment in depressive disorders. The neurobiological mechanisms underlying these therapeutic effects of T3 are still unknown. Since brain serotonin (5-HT) changes have been implicated in the mode of action of TCA drugs, the effects of a chronic (7 or 21 days) administration of imipramine (10 mg/kg/day) and of a low dose of T3 (4 μg/kg/day), given alone or in combination, were investigated on the density of midbrain 5-HT transporters and of hippocampal 5-HT1A and cortical 5-HT2A receptors in adult Wistar rats. Neither single nor combined administration of imipramine and T3 for 7 days modified the density of 5-HT transporters and of 5-HT1A receptors. On day 21, the combination did not change imipramine- or T3-induced decrease in 5-HT transporter density whereas it prevented imipramine-induced increase in 5-HT1A receptor density. Whatever the treatment duration, imipramine-T3 combination potentiated imipramine-induced decrease in 5-HT2A receptor density. On both day 7 and day 21, T3 given alone had no effects on the density of 5-HT1A and 5-HT2A receptors. These data indicate that T3 is able to modulate the long-term adaptive changes which occur at the postsynaptic level of 5-HT neurotransmission after antidepressant treatment.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aronson R, Offman HJ, Joffe RT, Naylor CD . (1996): Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 53: 842–848
Barsano CH, Garces J, Iqbal Z . (1994): Metabolic implications of low-dose triiodothyronine administration in rats: Relevance to the adjunctive use of triiodothyronine in the treatment of depression. Biol Psychiatry 35: 814–823
Bel N, Artigas F . (1996): In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. J Pharmacol Exp Ther 278: 1064–1072
Blier P, de Montigny C . (1994): Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220–226
Bradford MM . (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Breese GR, Traylor TD, Prange AJ . (1972): The effect of triiodothyronine on the disposition and actions of imipramine. Psychopharmacologia 25: 101–111
Burnet PW, Michelson D, Smith MA, Gold PW, Sternberg EM . (1994): The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res 638: 311–324
Chaput Y, de Montigny C, Blier P . (1991): Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5: 219–229
Cheetham SC, Viggers JA, Slater NA, Heal DJ, Buckett WR . (1993): [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 32: 737–743
Coppen A, Whybrow PC, Noguera R, Maggs R, Prange AJ . (1972): The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry 26: 234–241
Dean B, Pereira A, Pavey G, Singh B . (1997): Repeated antidepressant drug treatment, time of death and frequency of handling do not affect [3H]paroxetine binding in rat cortex. Psychiatry Res 73: 173–179
de Montigny C, Aghajanian GK . (1978): Tricyclic antidepressants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202: 1303–1306
Dewar KM, Grondin L, Nenonene EK, Ohayon M, Reader TA . (1993): [3H]paroxetine binding and serotonin content of rat brain: Absence of changes following antidepressant treatments. Eur J Pharmacol 235: 137–142
Eison AS, Mullins U . (1996): Regulation of central 5-HT2A receptors: a review of in vivo studies. Behav Brain Res 73: 177–181
Escobar-Morreale HF, Escobar del Rey F, Obregon MJ, Morreale de Escobar G . (1996): Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of thyroidectomized rat. Endocrinology 137: 2490–2502
Feighner JP, King LJ, Schuckit MA, Croughan J, Briscoe W . (1972): Hormonal potentiation of imipramine and ECT in primary depression. Am J Psychiatry 128: 1230–1238
Gallager DW, Bunney WE Jr . (1979): Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity. Naunyn Schmiedebergs Arch Pharmacol 307: 129–133
Garbutt J, Malepour B, Brunswick D, Jonnalagadda MR, Jolliff L, Podolak R, Wilson I, Prange AJ . (1979): Effects of triiodothyronine on drug levels and cardiac function in depressed patients treated with imipramine. Am J Psychiatry 136: 980–982
Goodwin GM, Green AR, Johnson P . (1984): 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83: 235–242
Gravel P, de Montigny C . (1987): Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment. Synapse 1: 233–239
Gupta S, Masand P, Tanquary JF . (1991): Thyroid hormone supplementation of fluoxetine in the treatment of major depression. Br J Psychiatry 159: 866–867
Gur E, Lerer B, Newman ME . (1999): Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: Relationship to serotonin autoreceptor activity. J Pharmacol Exp Ther 288: 81–87
Heninger GR, Charney DS . (1987): Mechanisms of action antidepressant treatment: Implications for the etiology and treatment of depressive disorders. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp 535–544
Joffe RT . (1988): Triiodothyronine potentiation of the antidepressant effect of phenelzine. J Clin Psychiatry 49: 409–410
Joffe RT . (1992): Triiodothyronine potentiation of fluoxetine in depressed patients. Can J Psychiatry 37: 48–50
Joffe RT, Singer W . (1990): A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 32: 241–251
Joffe RT, Sokolov ST . (1994): Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 8: 45–63
Joffe RT, Sokolov ST, Singer W . (1995): Thyroid hormone treatment of depression. Thyroid 5: 235–239
Kennedy JA, Jarrett DB, Wellby ML . (1997): Influence of imipramine on the hypothalamic/pituitary/thyroid axis of the rat. Metabolism 46: 1429–1434
Klimek V, Zak-Knapik J, Mackowiak M . (1994): Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci 19: 63–67
Kovachich GB, Aronson CE, Brunswick DJ . (1992): Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. Neuropsychopharmacology 7: 317–324
Kulikov A, Moreau X, Jeanningros R . (1999): Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature brain. Neuroendocrinology 69: 453–459
Lafaille F, Welner SA, Suranyi-Cadotte BE . (1991): Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment. J Psychiatry Neurosci 16: 209–214
Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL . (1993): Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17: 31–35
Maes M, Meltzer HY . (1995): The serotonin hypothesis of major depression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, pp 933–944
Maj J, Bijak M, Dziedzicka-Wasylewska M, Rogoz R, Rogoz Z, Skuza G, Tokarski T . (1996): The effects of paroxetine given repeatedly on the 5-HT receptor subpopulation in the rat brain. Psychopharmacology 127: 73–82
Munson PJ, Rodbard D . (1980): Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220–239
Nankai M, Yamada S, Toru M . (1991): Downregulation of serotonin uptake sites in rat brain induced by concomitant chronic administration of desipramine and repeated stress. Jpn J Psychiatry Neurol 45: 105–106
Newton RA, Elliot JM . (1997): Mianserin-induced downregulation of human 5-hydroxytryptamine-2A and 5-hydroxytryptamine-2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y. J Neurochem 69: 1031–1038
Papp M, Klimek V, Willner P . (1994): Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology 114: 309–314
Peroutka SJ, Snyder SH . (1980): Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther 215: 582–587
Piñeyro G, Blier P, Dennis T, de Montigny C . (1994): Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14: 3036–3047
Prange AJ, Wilson IC, Rabon AM, Lipton MA . (1969): Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 126: 457–469
Roth BL, Ciaranello . (1991): Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels. Eur J Pharmacol 207: 169–172
Roth BL, Berry SA, Kroeze WK, Willins DL, Kristiansen K . (1998): Serotonin 5-HT2A receptors: molecular biology and mechanism of regulation. Crit Rev Neurobiol 12: 319–338
Rudorfer MV, Potter WZ . (1989): Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the ‘newer’ versus the ‘older’ drugs. Drugs 37: 713–738
Sandrini M, Vitale G, Vergoni AV, Ottani A, Bertolini A . (1996): Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain. Life Sci 58: 1551–1559
Sibille E, Sarnyai Z, Benjamin D, Gal J, Baker H, Toth M . (1997): Antisense inhibition of 5-hydroxytryptamine 2A receptor induces an antidepressant-like effect in mice. Mol Pharmacol 52: 1056–1063
Steiner M, Radwan M, Elizur A, Blum I, Atson A, Davidson S . (1978): Failure of L-triiodothyronine (T3) to potentiate tricyclic antidepressant response. Curr Ther Res 23: 655–659
Subhash MN, Jagadeesh S . (1997): Imipramine-induced changes in 5-HT2 receptor sites and inositoltrisphosphate levels in rat brain. Neurochem Res 22: 1095–1099
Thomas DR, Nelson DR, Johnson AM . (1987): Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 93: 193–200
Watanabe Y, Sakai RR, McEwen BS, Mendelson S . (1993): Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 615: 87–94
Welner SA, de Montigny C, Desroches J, Desjardins P, Suranyi-Cadotte BE . (1989): Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 4: 347–352
Wheatley D . (1972): Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 26: 229–233
Wilson IC, Prange AJ, McClane TK, Rabon AM, Lipton MA . (1970): Thyroid-hormone enhancement of imipramine in nonretarded depressions. N Engl J Med 282: 1063–1067
Acknowledgements
We thank Mrs. H. Rescigno for her technical assistance and Dr. P.J. Lejeune (Laboratoire de Biochimie Endocrinienne et Métabolique, Faculté de Médecine, Marseille) for his help in thyroid hormone determinations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreau, X., Jeanningros, R. & Mazzola-Pomietto, P. Chronic Effects of Triiodothyronine in Combination with Imipramine on 5-HT Transporter, 5-HT1A and 5-HT2A Receptors in Adult Rat Brain. Neuropsychopharmacol 24, 652–662 (2001). https://doi.org/10.1016/S0893-133X(00)00234-7
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(00)00234-7
